Amneal Pharmaceuticals (AMRX) Debt to Equity (2017 - 2026)
Amneal Pharmaceuticals (AMRX) recorded quarterly Debt to Equity of -$56.63 in Q1 2026, down 55.89% quarter-over-quarter from -$36.33 in Q4 2025, and down 242.01% on a YoY basis from $39.88 in Q1 2025.
Amneal Pharmaceuticals (AMRX) Debt to Equity (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Debt to Equity history runs 10 years deep, the most recent figure standing at -$56.63 for Q1 2026.
- In Q1 2026, Debt to Equity fell 242.01% year-over-year to -$56.63; the TTM figure through Mar 2026 stood at -$56.63 (down 242.01% YoY), while the FY2025 annual figure was -$36.33, down 66.74% from the prior year.
- Debt to Equity was -$56.63 for Q1 2026 at Amneal Pharmaceuticals, down from -$36.33 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $120.94 in Q4 2023 to a low of -$56.63 in Q1 2026.
- Historically, Debt to Equity has averaged -$5.45 across 5 years, with a median of -$16.56 in 2025.
- The sharpest annual moves came in 2023 and 2024: Debt to Equity surged 11201.99% in 2023, then plunged 339.58% in 2024.
- A 5-year view of Debt to Equity shows it stood at $14.41 in 2022, then surged by 739.01% to $120.94 in 2023, then sank by 118.02% to -$21.79 in 2024, then tumbled by 66.74% to -$36.33 in 2025, then sank by 55.89% to -$56.63 in 2026.
- The last three Debt to Equity figures came in at -$56.63 (Q1 2026), -$36.33 (Q4 2025), and -$23.41 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.02 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.80 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.61 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.86 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.47 |
| 10 | Amneal Pharmaceuticals | 4.66 Bn | 4.65 Bn | 320.11 Mn | -56.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.63 |
| Dec 31, 2025 | -36.33 |
| Sep 30, 2025 | -23.41 |
| Jun 30, 2025 | -21.65 |
| Mar 31, 2025 | -16.56 |
| Dec 31, 2024 | -21.79 |
| Sep 30, 2024 | -24.68 |
| Jun 30, 2024 | -40.99 |
| Mar 31, 2024 | -40.18 |
| Dec 31, 2023 | 120.94 |
| Sep 30, 2023 | 16.97 |
| Jun 30, 2023 | 17.11 |
| Mar 31, 2023 | 19.13 |
| Dec 31, 2022 | 14.41 |
| Sep 30, 2022 | 0.51 |
| Jun 30, 2022 | 0.40 |
| Mar 31, 2022 | 0.17 |
| Dec 31, 2021 | 0.19 |
| Sep 30, 2021 | 0.18 |
| Jun 30, 2021 | 7.05 |